The American Association of Clinical Endocrinologists (AACE) has updated its postmenopausal osteoporosis guidelines. The new guidelines cover risk factors and fall prevention measures in more detail than prior guidelines. Pharmacological treatment is recommended for patients with osteoporosis, patients with osteopenia who have had a fragility fracture of the hip or spine, and for patients with osteopenia who have a 10-year FRAX major fracture risk at or above 20%, or a 10-year FRAX hip fracture risk of 3% or above. https://www.aace.com/files/final-appendix-sept-7.pdf
Category: Osteoporosis
